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 ABSTRACT 
Introduction/Purpose To investigate whether a) lower levels of daily physical activity (PA) and 
greater sedentary time accounted for contrasting metabolic phenotypes (higher liver fat/presence 
of metabolic syndrome [MetS+] vs lower liver fat/absence of metabolic syndrome [MetS-]) in 
individuals of similar BMI and b) the association of sedentary time on metabolic health and liver 
fat. Methods Ninety-eight habitually active participants (53 female, 45 male; age 39±13 years; 
BMI 26.9±5.1 kg/m
2                                                 ;            98    
      -                        2 peak), body composition (MRI and MRS) and multi-organ 
insulin sensitivity (OGTT). We undertook a) cross-sectional analysis comparing four groups: 
non-obese or obese, with and without metabolic syndrome (MetS+ vs MetS-) and b) univariate 
and multivariate regression for sedentary time and other levels of PA in relation to liver fat. 
Results Light, moderate and vigorous PA did not account for differences in metabolic health 
between individuals, whether non-obese or obese, although MetS+ individuals were more 
                                                       1-2                                  
                         2 peak were each independently associated with liver fat percentage. 
Each additional hour of daily sedentary time was associated with a 1.15% (95% CI, 1.14–1.50%) 
higher liver fat content. Conclusions Greater sedentary time, independent of other levels of PA, 
is associated with being metabolically unhealthy; even in habitually active people, lesser 
sedentary time, and higher cardio-respiratory fitness and average daily METS is associated with 
lower liver fat. KEY WORDS: Body composition, magnetic resonance spectroscopy, metabolic 
syndrome, insulin regulation, cardio-respiratory fitness, metabolic equivalents 
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 INTRODUCTION  
Strong epidemiologic evidence suggests an inverse relationship between physical activity (PA) 
levels and obesity, metabolic syndrome (MetS), non-alcoholic fatty liver disease (NAFLD) and 
type 2 diabetes (1-5). Increased PA is recommended both for individuals and at a population 
level to improve metabolic health and help prevent these interrelated conditions. The 
independent protective effect of high cardio-respiratory fitness (CRF), an objective marker of 
PA, against all-cause mortality is well established (6, 7). There is a growing recognition that 
sedentary behaviour, which has an independent association with adverse health outcomes, should 
be minimised (2, 8, 9). Increasing moderate PA is protective against the aforementioned diseases 
and attenuates, but does not eliminate, the detrimental effects of sedentary behaviour (10). 
Breaking up prolonged periods of sedentary time (11) or replacing it with low-intensity PA (12) 
are beneficial for glycaemic control. 
Obesity is strongly associated with poor cardio-metabolic health and overall mortality (13). 
However, not all obese individuals are metabolically unhealthy (MetS+) (14); conversely not all 
non-obese individuals are metabolically healthy (MetS-) (15). Some studies suggest that MetS+ 
may be a consequence of low PA (16, 17), but others have not supported this conclusion (18-20). 
With differences in methodology, cohort characteristics and definitions of metabolic phenotypes, 
these studies typically have not precisely defined the differences in PA characteristics between 
phenotypes. Only one study, of older adults, has objectively measured sedentary behaviour (19), 
which offers better reliability than self-report (21); no such study has been undertaken in young-
middle aged adults. There are similarly conflicting results in studies of the association of 
metabolic health with objectively measured sedentary behaviour and quantitative measures of 
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 liver fat using magnetic resonance spectroscopy (MRS) or computed tomography (CT) (22-26). 
The accumulation of liver fat has been described as a major contributor to the development of  
type 2 diabetes (27), is considered the hepatic manifestation of MetS and closely linked with 
obesity and insulin resistance (28). Observing levels of PA, including sedentary behaviour,  in 
metabolic phenotypes of a given BMI category with further quantification of liver fat may reveal 
associations which link habitual activity to health outcomes and the predisposition for metabolic 
diseases.  
This cross-sectional study will objectively monitor the  habitual PA of young-middle aged adults 
and extensively phenotype these individuals by assessment of metabolic health and MRI-derived 
body composition. We hypothesise that, greater sedentary time and lower levels of PA will be 
evident in metabolically unhealthy phenotypes (MetS+ vs MetS-) in BMI-matched individuals; 
and secondly, higher MRS-quantified liver fat will be associated with greater sedentary time and 
lower PA levels.  
METHODS 
Participants  
Habitually active individuals who engaged in no more than 2 hours of exercise per week, were 
recruited via local advertisements across University of Liverpool campuses and hospital 
departments. Exclusions included cardiovascular, respiratory, kidney, liver and/or endocrine 
complications, smoking and >14 units/week of alcohol consumption. The study conformed to the 
Declaration of Helsinki and was approved by the North West Liverpool Central research ethics 
committee (14/NW/1145; 14/NW/1147; 15/NW/0550). All participants were informed of the 
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 methods verbally and in writing before providing written informed consent prior to any 
assessments. Ninety-eight individuals (52 male, 46 female) with a mean age of 39±13 years and 
BMI 27±5 kg/m
2
 were recruited. Prior to each study visit, participants were required to fast 
overnight for 12 hours (water was permitted ad libitum), abstain from alcohol and caffeine for 24 
hours and from exercise for 48 hours. 
Study design  
All participants completed measurement of baseline PA and dietary consumption over a period 
of 4 days (including one weekend day) between January 2016 and Febuary 2017 followed by 
assessment in the the order of a) anthropometry (including bio-impedance), fasting biochemistry, 
an oral glucose tolerance test (OGTT) and assessment of CRF     2 peak) at University Hospital 
Aintree and b) magnetic resonance imaging (MRI) and proton magnetic resonance spectroscopy 
(
1
H-MRS) at the University of Liverpool MRI Centre (LiMRiC). Due to MRI scanner 
replacement during part of this study, MRI quantification of body fat was conducted in only 72 
individuals. Bio-impedance data was collected in all individuals, and   2 peak calculations were 
based on both total body mass and fat free mass (FFM).  
Individual phenotyping  
Individuals were characterised into one of four groups based on BMI (non-obese <30 vs obese 
≥30 k / 2) and the presence or absence of MetS according to International Diabetes Federation 
(IDF) criteria; we refer to these groups as    ‘non-obese MetS-’      ‘non-obese MetS+’       
‘obese MetS-’         ‘obese    +’.  
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 Habitual assessment 
Physical activity monitoring PA was monitored throughout using a validated (29) SenseWear 
mini armband (BodyMedia Inc., Pittsburgh, PA, USA). Wear time (recorded as ~98%) was 
monitored using SenseWear Professional software (version 8.0). Data included: daily average 
step count, total energy expenditure, active energy expenditure and time spent in levels of PA 
including: sleep, lying down, sedentary (<1.5 METS), light (1.5-3 METS), moderate (3-6 
METS), vigorous (6-9 METS) and very vigorous (>9 METS). A Microsoft Excel template, as 
previously described (30), was used to determine how sedentary time (not including sleep) was 
accumulated and provided information on the frequency of bouts and the time accumulated in a 
given bout category (<1 h: 1–5, 6–10, 11–20, 21–40, 41-60 min; 1-2 h: 61-80, 81-100, 101-120 
min; >2 h: 121-140, 141-160, 161-180 min). To examine ‘   q          k  ’ periods of 
sedentary time, the given bout categories at the lower end (<1 h) were shorter in duration. At the 
higher end (> 1h), where fewer bouts are recorded, the given bout categories are greater in 
duration. Based on previous observations (31), this approach was adopted to investigate 
‘patterns’ of sedentary time, i.e. the frequency with which sedentary time is interrupted 
(sedentary breaks) or the duration of uninterrupted periods of sedentary time (sedentary bouts).  
Furthermore, moderate-vigorous PA (MVPA) of bouts greater or less than 10 minutes were 
determined.    
Dietary analysis Total energy consumption, carbohydrate, protein and fat content were 
determined from 4-day dietary records by a registered nutritionist (KM) using Nutritics 
(Nutrition Analysis Software for Professionals; https://www.nutritics.com/p/home). 
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 Other assessment measures 
Anthropometric measurements Stature (Model 220, Seca, Germany) and whole-body bio-
impedance analysis (Tanita, BC 420, Dolby Medical Stirling, UK) was conducted; this provided 
total body mass, fat percentage, fat mass, fat free mass, muscle mass, total body water, basal 
metabolic rate, bone mass and visceral fat indicator. Waist and hip circumference measurements 
were taken in duplicate and blood pressure was determined from an average of three measures 
(Dinamap, G & E Medical, USA). 
Biochemical measurements Blood samples were collected and analysed using the Olympus 
AU2700 analyser (Beckman Coulter, High Wycombe, UK) with standard proprietary reagents as 
follows: glucose with hexokinase, total cholesterol and HDL with cholesterol esterase/oxidase 
and triacylglycerol with glycerol kinase. LDL was calculated according to the Friedwald 
formula. Insulin was measured using radio-immunoassay (Invitrogen, UK). HOMA-IR was 
calculated using fasting glucose and insulin concentrations.  
OGTT Following a 12hr fast, blood samples were collected, a 75 g glucose drink was consumed 
within 5 min and post-ingestion blood samples were drawn at 30, 60, 90 and 120 min. Matsuda 
index was calculated to estimate whole body IS, and indices of hepatic-IR and skeletal muscle IS 
were determined as previously described (32). 
CRF      2 peak cardio-pulmonary exercise test (CPET) was performed on a treadmill (Model 
77OCE, RAM Medisoft Group, Manchester, UK) in a temperature-controlled room. The CPET 
provided breath-by-breath monitoring and analysis of expiratory gases and ventilation (Love 
Medical Cardiopulmonary Diagnostics, Manchester, UK). The modified Bruce protocol     
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                            2                2 2 k /                          -                   
                                                 2 peak was determined by exhaustion plus 
one or more of: respiratory exchange ratio >1.15, heart rate >90                             
     2.  
1
H-MRS Liver and skeletal muscle fat were determined using a 1.5 T Siemens Symphony MRI 
scanner as previously described (33).  
Statistical analysis  
All data were explored for normality using visual inspection of frequency distribution, and 
logarithmically transformed where appropriate. Given the small sample size, power achieved on 
each test was assessed and ranged from 46 to >99%; 20 of 26 achieved at least 80% power.  Age 
was analysed using a one factor between-groups ANOVA whereby a significant group effect was 
observed (P<0.05). Between-group univariate general linear models (GLM) were conducted for 
all other variables, with age as a covariate and Bonferroni correction for multiple comparisons. 
Statistically significant interactions were explored and nominal P-values reported. Univariate 
and multivariate linear regression were used to analyse components of PA and fitness associated 
with liver fat. Decisions were made a priori to include all variables reaching P<0.1 in univariate 
regression analysis alongside age and BMI in the multivariate regression model. The statistical 
cut-off for inclusion in the final model is more stringent than often used to guard against false 
discovery. The alpha level of statistical significance was set at P<0.05. Data are presented as 
mean (95% CI), unless stated otherwise. Transformed data were back-transformed to original 
units. P value >1 rounded to 1.000. 
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 RESULTS 
Participant characteristics 
The numbers of individuals with each risk factor of MetS are summarised in Table 1, with the 
PA and CRF data of the whole cohort combined. Calculated from their average of 4 d MVPA 
(accumulated in bouts of >10 min), 61% of individuals met the World Health Organisation 
(WHO) recommendations. 
Metabolic phenotyping  
The si                                        ’               MetS were in line with IDF 
classification (Table 2).  There was no significant difference between obese MetS- and obese 
MetS+ BMI (P=0.712) but non-obese MetS+ BMI was 3±2 kg/m
2
 greater than non-obese MetS- 
(P=0.003). In the general population, MRS defined liver fat >5.5% corresponds with the 
prevalence of hepatic steatosis (34); 84 and 14 participants had liver fat <5 5      ≥5.5% 
respectively.  
Dietary intake  
Total energy consumption, carbohydrate, protein and fat did not differ significantly between 
groups (P>0.05). Mean ±SD macronutrient percentages were 56±16% carbohydrate, 24±9% 
protein, and 20±7% fat.  
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 CRF  
Obese MetS+ individuals had lower CRF than both obese and non-obese MetS- (P≤0 029; mean 
           ≥7 5 mL·min-1·kg-1) but not non-obese MetS+ (P=0.675; mean difference 5.9 
mL·min
-1
·kg
-1
) There was no difference between both non-obese groups and obese MetS- 
(P≥0 080  (Fig. 1a).  
Multi-organ IS  
Non-obese MetS- individuals had greater Matsuda index than non-obese MetS+ (P=0.012; mean 
difference 2.0) (Fig. 1b); there was no difference between obese MetS- and both MetS+ groups 
(P≥0 141). There was no group effect for skeletal muscle IS index (P=0.220). Hepatic-IR index 
was greater in obese MetS+ than non-obese MetS- (Fig. 1c). There was a significant group effect 
(P=0.022) for HOMA-IR.  
MRS quantification of liver fat  
Liver fat was higher in MetS+ in both non-obese and obese. Non-obese MetS- individuals had 
4.6% lower liver fat than obese MetS+ (P≤0 005) (Fig. 1d). Liver fat percentage in non-obese 
MetS+ was not different to either obese group (P≥0 794; mea             ≥0 6   ; and liver fat 
percentage in obese groups was not statistically different (P=0.336; mean difference 2.6 %).  
Levels of physical activity: differences between the 4 metabolic phenotypes 
Average daily steps: There was no group effect for average daily steps (Fig. 2a).  
Non-sleep sedentary time, lying time and sleep duration: Non-sleep sedentary time (Fig. 2b) was 
not different between non-obese groups (P=1.000; 49 min/day) and obese groups (P=1.000; 23 
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 min/day). Non-obese MetS- individuals had lower sedentary time than obese MetS+ (P=0.04); 
there was no difference between obese MetS- and both MetS+ groups (P≥0 199). There was no 
group effect for amount of time spent lying down (P=0.080) or sleeping (P=0.117).  
Daily light PA time: There was no difference in daily light activity between both non-obese 
groups (P=0.711; mean difference 10 min/day) and both obese groups (P=1.000; 9 min/day). 
However, both obese groups had less light activity than both non-obese MetS- (P≤0 015; mean 
           ≥69   /     (Fig. 2c).   
Daily moderate-vigorous PA time: There was no difference between the groups’ moderate-
vigorous activity (P=0.322) (Fig. 2d) and no significant differences were found for the way in 
which MVPA was accumulated for bouts of 10 minutes or more, in either total minutes 
accumulated or percentage of the time in relation to total MVPA.  
Average daily METS and PA duration: Daily average METS (Fig. 2e) and PA duration (Fig. 2f) 
had significant group effects (P<0.0005 and P=0.020, respectively); for both measures, non-
obese MetS- had greater values than both obese groups, but were not different to non-obese 
MetS+. Daily average METS in non-obese MetS- were 0.3 METS greater than both obese groups 
(P<0.0005). The same was observed for PA duration, with non-obese MetS- having greater 
duration that both obese groups (P≤0 018;                 ≥107    /                   
significant difference between obese MetS- and both MetS+ groups for average daily METS and 
PA duration (P≥0 079     P≥0 450                 
Patterns of waking sedentary time: Analysis of sedentary behaviour was performed on waking 
sedentary time examining the duration of sedentary time (Fig. 3a) and the number of sedentary 
bouts (Fig. 3b) in a pre-determined bout category. There were no differences between the groups 
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 in sedentary bout durations of < 1 h or > 2 h. However, significant differences were apparent 
during bout durations lasting between 1 and 2 h. Duration: during bouts of 61-80 min, non-obese 
MetS+ accumulated 33 min more sedentary time per day than non-obese MetS- (3, 60; P=0.013). 
During bouts of 81-100 min, MetS+ obese accumulated 34 min per day more than obese MetS- 
(6, 62; P=0.018). During bouts of 101-120 min, obese MetS+ accumulated 28 min per day more 
than obese MetS- (5, 51; P=0.018). Number of bouts: as an average of 4 days, both MetS+ 
groups accumulated 1-2 more long bouts (between 1-2 h) of sedentary behaviour, compared to 
their MetS- counterparts. Considering bouts of 61-80 min, non-obese MetS+ had 0.5 more bouts 
per day (0.1, 0.9; P=0.012) than MetS-. Obese MetS+ had 0.4 more bouts per day (0.1, 0.7; 
P=0.019) than MetS- of 81-100 min and 0.3 more bouts per day (0.1, 0.5; P=0.017) of 101-120 
min.  
Levels of physical activity (regression analysis): Univariable linear regression analysis revealed 
that daily average steps, sedentary time,                                2 peak were all 
significantly associated with liver fat. Carried forward in the multivariable analysis, three of 
these factors remained statistically significant predictors of liver fat (Table 3). Greater daily 
sedentary time is associated with higher liver fat, while                                2 peak 
are associated with lower liver fat (Fig. 3). For a one hour increase in sedentary time, liver fat 
increased by 1.15% (1.14–1.50%; P=0.036) while for a 1 mL·min-1·kg-1 increase in CRF (    2 
peak), liver fat reduced by 0.87% (0.25, 1.50; P=0.007). 
DISCUSSION  
The results of this extensive phenotypic analysis of objective measurements of PA and sedentary 
behaviour, metabolic and body composition measurements (including MRS-derived liver fat) in 
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 young-middle aged adults demonstrate two key messages. Firstly, in this cohort, overall habitual 
PA was not associated with different metabolic health status in individuals of similar BMI, and 
the accumulation of sedentary time was weakly associated with the presence of the MetS. 
Secondly, even in habitually active individuals, there is an association between greater sedentary 
time and increased liver fat, while the amount of moderate-vigorous PA (MVPA) appeared to 
have little independent association. These data highlight the potential importance of sedentary 
behaviour in determining optimal metabolic health and liver fat.  
It is recognised that greater sedentary time increases the risk of becoming overweight/obese (35) 
and the risk of type 2 diabetes and cardiovascular disease, even after controlling for MVPA (8, 
36). Whilst total volumes of habitual PA do not explain metabolic health in this cohort, those 
with MetS shown some evidence of being more sedentary, with a higher number of prolonged 
bouts of sedentary behaviour (between 1-2 hours). Frequent breaks in sedentary time have been 
shown to be beneficial to metabolic risk (31), health (37) and liver fat (24).  To our knowledge, 
there are no studies which have investigated sedentary bouts greater than 1 hour. Interestingly, an 
extra hour of sedentary time has been associated with a 39% increased odds for MetS (38) and 
decreasing sedentary time accumulated in prolonged bouts may have beneficial effects om BMI 
and waist circumference (39). Futher research at durations of >1 hour may reveal insight into the 
the pattern in which sedentary time is accumulated and MetS. Even individuals who are 
physically active can still spent a significant amount of their waking day sedentary, (termed 
previously sedentary exercisers’ (40)) which is associated with increased cardio-metabolic risk. 
Taken together, these findings suggest that public health and chronic disease prevention 
strategies that largely focus on MVPA recommendations, might benefit from new 
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 recommendations regarding interruption of prolonged sedentary time, complimentary to those of 
PA. 
Numerous prospective studies have confirmed the relationship between PA and liver fat (5, 41-
44) and compliance with national MVPA guidelines has been associated with a lower odds of 
NAFLD (26). Furthermore, recent research in a population-based sample of adults has       
        2 peak is strongly, inversely and independently related to the risk of liver fat (45). The 
results presented are in agreement with previous research, greater levels of PA (here daily 
METs) and higher CRF is independently associated with lower levels of liver fat. Importantly, 
the associations between CRF and liver fat remained after adjustment for BMI; not all studies 
have reported similar findings (46). The association between sedentary time and liver fat is 
equivocal.  Some authors have found no associations between PA or sedentary behaviour and 
liver fat in 82 individuals (25, 26). Whereas others have concluded that PA and sedentary time 
are indeed independently associated with the prevalence of NAFLD (22, 24). In inactive 
individuals every hour of sedentary time was associated with increases of 1.74 L of total 
abdominal fat, 0.62 L of visceral fat, 1.14 L of subcutaneous fat, and 1.86% liver fat (22). Direct 
comparisons or broad conclusions are difficult due to differences in cohorts and methodology. 
The findings of the current study suggest that sedentary time has an independent effect on liver 
fat in active adults, however more data is required to confirm this. Our results demonstrating that 
every hour of additional sedentary time translates to a 1.15% increase in liver fat, can be put into 
context by comparing the effects of a 4 week aerobic cycling intervention in sedentary obese 
men and women, where liver fat reduced by 1.7% (47).  The effects surgical, nutritional, lifestyle 
or pharmaceutical interventions aiming to reduce liver fat has been recently reviewed (48).  
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 This study utilises objective monitoring of PA, gold standard measurement of CRF and MRS-
derived liver fat in young-middle aged adults, all of which are key strengths. The results did not 
support any strong evidence for a beneficial association of sedentary bouts <1 hour or 
detrimental association of >2 hours perhaps due to study limitations which include the relatively 
small sample size. Further limitations include: duration of PA assessment, the monitor used to 
assess sedentary behaviour (SenseWear does not determine postural differences), the 
comparatively healthy habitual PA habits of the participants which somewhat limits the external 
validity of the findings, and the cross-sectional design which cannot determine causality. 
Noteworthy is the higher BMI in unhealthy non-obese versus healthy non-obese which confirms 
to the association of a greater BMI with greater metabolic risk. This difference could not be 
controlled for as it was a component of our grouping analysis but differences in age were 
statistically controlled for. While the present results demonstrate that overall sedentary time 
needs to be considered independently of PA, objective PA monitoring in a larger cohort with a 
prospective design will be required and future research should further explore sedentary 
behaviour patterns (i.e. amount of sedentary breaks and duration of sedentary bouts). The 
         D                                                       ‘decrease the amount of 
time spent daily in sedentary behaviour’          ‘prolonged sitting should be interrupted with 
bouts of light activity every 30 min’  I                                                            
                                                 ‘   -   ’                                          
(i.e. frequency/duration) has not been defined in public health guidelines. 
In summary, in habitually active adults, the amount of sedentary time is associated in this single-
measure observation with metabolic health and the quantity of liver fat. The findings of this 
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 study highlight that public health policy designed to optimise the benefits of physical activity 
may need to synergistically consider strategies to reduce sedentary behaviour. 
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 Figure legends 
Figure 1       -                                                       :    2 peak relative to fat 
free mass (FFM) (a), whole body insulin sensitivity (b), hepatic insulin resistance index (c) and 
liver intrahepatocellular lipid (IHCL) (d). Data are presented as mean ± SD. Grey circles, MetS-; 
white circles, MetS+; non-obese are grouped left and obese are grouped right. *P<0.05 group 
difference between BMI category, further group differences being given in the text. 
Figure 2 Habitual physical activity and sedentary time, individual participant plots for: average 
daily steps (a), non-                      <1 5                            1 5−3            
moderate-vigorous activity (>3 METS) (d), daily metabolic equivalents (METS) (e) and physical 
activity (PA) duration (f). Data are presented as mean ± SD. Grey circles, MetS-; white circles, 
MetS+; non-obese are grouped left and obese are grouped right. *P<0.05 group difference 
between BMI category, further group differences being given in the text. 
Figure 3 Non-sleep sedentary behaviour, individual participant plots for: duration of sedentary 
bouts (a) and number of sedentary bouts in given bout category (b) between 1-2 h. Data are 
presented as mean ± SD. Grey circles, MetS-; white circles, MetS+; non-obese are grouped left 
and obese are grouped right. *P<0.05 group difference between BMI category, further group 
differences being given in the text. 
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 Table 1 PA and CRF data, the number of risk factors of metabolic syndrome (MetS) and liver fat 
in 98 individuals. Classification column for risk factors is listed as MetS- (top) and MetS+ 
(bottom). 
 Mean ± SD  
Average daily wear time (%) 98 ± 4 
Average daily steps (steps/day) 10939 ± 3482 
Daily non-sleep sedentary time (min) 605 ± 125 
Daily light PA time (min) 241 ± 84 
Daily moderate-vigorous PA time (min) 143 ± 92 
Daily lying time (min) 486 ± 83 
Daily sleep duration (min) 403 ± 67 
Daily metabolic equivalents (METS) 1.6 ± 0.3 
   2 peak (mL·min
-1
·kg
-1
) 32.9 ± 8.2 
 Risk factor Classification N (%) 
Waist circumference (cm) 
<94M/80F 
≥94 /80F 
65 (66%) 
33 (34%) 
Triacylglycerol (mmol/L) 
≤1 7 
>1.7 
83 (85%) 
15 (15%) 
HDL-cholesterol (mmol/L) 
≥1 03 /1 29F 
<1.03M/1.29F 
91 (93%) 
7 (8%) 
Systolic BP (mmHg) 
≤130 
>130 
64 (65%) 
34 (35%) 
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 Diastolic BP (mmHg) 
≤85 
>85 
74 (76%) 
24 (24%) 
Fasting glucose (mmol/L) 
≤5 6 
>5.6 
88 (90%) 
10 (10%) 
PA, physical activity; HDL, high-density lipoprotein; BP, blood pressure; M, male   
classification; F, female classification. 
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 Table 2 Clinical, metabolic and body composition characteristics of participants categorised for obesity and subsequently according to 
MetS. 
 Non-obese Obese 
 MetS- (n=62) MetS+ (n=11) P MetS- (n=12) MetS+ (n=13) P 
Gender M n=30; F n=32 M n=9; F n=2 0.042
*
 M n=5; F n=7 M n=8; F  n=5 0.319 
Age (years) 34 (31, 38) 49 (43, 55) <0.0005
*
 45 (39, 50) 46 (39, 52) 0.902 
Weight (kg) 70.8 (68.1, 73.6) 80.8 (75.7, 85.9) 0.045
*
 96.3 (85.2, 107.4) 99.8 (91.7, 107.9) 0.470 
BMI (kg/m
2
) 24.1 (23.4, 24.8) 26.9 (25.7, 28.2) 0.018* 33.7 (30.6, 36.7) 34.1 (32.6, 35.6)  0.722 
Components of metabolic syndrome  
Waist circumference (cm) 85 (82, 87) 98 (93, 102) 0.005
*
 105 (96, 115) 111 (106, 116) 0.191 
Systolic BP (mmHg) 120 (117, 123) 144 (137, 151) <0.0005
*
 126 (117, 135) 147 (135, 158) <0.0005
*
 
Diastolic BP (mmHg) 75 (72, 77) 95 (85, 105) <0.0005
*
 77 (73, 80) 90 (82, 98) 0.001
*
 
Fasting glucose (mmol/L) 4.9 (4.8, 5.0) 5.4 (5.1, 5.6) 0.076 5.0 (4.7, 5.2) 5.7 (5.0, 6.4) 0.003
*
 
Triacylglycerol (mmol/L) 0.9 (0.8, 1.1) 1.5 (1.0, 1.9) 0.080 1.2 (0.6, 1.7) 1.8 (1.3, 2.4) 0.016
*
 
HDL-cholesterol (mmol/L)  1.8 (1.7, 1.9) 1.7 (1.2, 2.1) 0.527 1.6 (1.3, 2.0) 1.3 (1.6, 1.8) 0.133 
MRI derived body composition                 n=48                         n=8                                                   n=8                          n=8 AC
CE
PT
ED
 Total body fat (L) 21.3 (18.9, 23.7) 25.8 (20.1, 31.5) 0.164 39.6 (33.6, 45.6) 39.1 (33.2, 44.7) 0.882 
Total SAT (L) 16.5 (14.2, 18.8) 18.6 (13.1, 24.1) 0.492 30.5 (24.7, 36.3) 28.2 (22.7, 33.8) 0.562 
Total internal fat (L) 4.7 (4.1, 5.4) 7.3 (5.7, 8.9) 0.006
*
 9.2 (7.5, 10.9) 8.5 (6.9, 10.2)  0.552 
Abdominal SAT (L) 4.5 (3.5, 5.5) 5.7 (3.3, 8.1) 0.374 9.7 (7.2, 12.3) 12.1 (9.7, 14.6) 0.162 
VAT (L) 2.3 (1.9, 2.8) 4.2 (3.1, 5.2) 0.002
*
 5.2 (4.1, 6.2) 5.7 (4.5, 6.8) 0.490 
VAT: abSAT ratio 0.6 (0.5, 0.7) 0.7 (0.5, 0.9) 0.333 0.6 (0.4, 0.8) 0.6 (0.4, 0.8) 0.793 
Data shown are mean (95% CI) and P values between groups 
*
P<0.05 
SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue; abSAT, abdominal SAT 
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 Table 3 Multivariate regression for liver fat percentage (%). 
 β coefficient 95% CI P  
Liver fat % 
Age (years) 1.00 1.00, 1.02 0.343 
BMI (kg/m
2
) 1.01 0.97, 1.12 <0.0005
*
 
Average daily steps (1,000) -0.97 -0.89, -0.97 0.103 
Average daily sedentary time (h) 1.15 1.14, 1.50 0.036
*
 
Average daily vigorous activity (min) -0.01 -0.01, 0.01 0.273 
Average daily METS (0.1) -0.48 -0.13, -0.56 0.012
*
 
   2 peak (mLmin
−1kg−1) -0.87 -0.25, -1.50 0.007
*
 
 
Liver fat data was transformed and analysed using 1og10, the data presented here is back transformed to original units.  
*
P<0.05 
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